Management Issues of Sarcoidosis in the Time of Coronavirus Disease 2019.
作者信息
Tana Claudio, Schiavone Cosima, Cipollone Francesco, Giamberardino Maria Adele
机构信息
COVID-19 Medicine Unit, Chieti, Italy.
SS. Annunziata Hospital; Internistic Ultrasound Unit, Chieti, Italy.
出版信息
Chest. 2021 Mar;159(3):1306-1307. doi: 10.1016/j.chest.2020.09.267.
Abstract
摘要
相似文献
1
Management Issues of Sarcoidosis in the Time of Coronavirus Disease 2019.2019年冠状病毒病时期结节病的管理问题
Chest. 2021 Mar;159(3):1306-1307. doi: 10.1016/j.chest.2020.09.267.
2
Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis.建模 COVID-19 和结节病中的潜在自噬途径。
Trends Immunol. 2020 Oct;41(10):856-859. doi: 10.1016/j.it.2020.08.001. Epub 2020 Aug 10.
3
Management of Immunosuppression During Severe COVID-19 Infection in a Patient With Pulmonary and Cardiac Sarcoidosis.肺和心脏结节病患者严重新型冠状病毒肺炎感染期间的免疫抑制管理
J Clin Rheumatol. 2020 Sep;26(6):229-232. doi: 10.1097/RHU.0000000000001557.
4
Detectable Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Human Breast Milk of a Mildly Symptomatic Patient With Coronavirus Disease 2019 (COVID-19).检测到轻度症状的 2019 冠状病毒病（COVID-19）患者的人乳中存在可检测的严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）。
Clin Infect Dis. 2021 Jan 23;72(1):128-130. doi: 10.1093/cid/ciaa673.
5
Moderate or Severe Impairment in Pulmonary Function is Associated with Mortality in Sarcoidosis Patients Infected with SARS‑CoV‑2.肺功能中重度受损与 SARS-CoV-2 感染的结节病患者的死亡率相关。
Lung. 2020 Oct;198(5):771-775. doi: 10.1007/s00408-020-00392-9. Epub 2020 Sep 11.
6
COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020.2020 年法国长期接受羟氯喹治疗的类肉瘤病患者中的 COVID-19 病例。
Emerg Infect Dis. 2020 Oct;26(10):2513-2515. doi: 10.3201/eid2610.201816. Epub 2020 Jul 1.
7
Important considerations regarding the future management of coronavirus (COVID-19).关于冠状病毒病（COVID-19）未来管理的重要考量因素。
Int J Surg. 2020 Jul;79:6-7. doi: 10.1016/j.ijsu.2020.04.083. Epub 2020 May 5.
8
[Determination Methods of 2019 Novel Coronavirus (SARS-CoV-2)].[2019新型冠状病毒（严重急性呼吸综合征冠状病毒2）的检测方法]
Zhongguo Yi Liao Qi Xie Za Zhi. 2020 Apr 8;44(4):359-362. doi: 10.3969/j.issn.1671-7104.2020.04.017.
9
Errors in Tracing Coronavirus SARS-CoV-2 Transmission Using a Maximum Likelihood Tree. Comment on "A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis".使用最大似然树追踪新型冠状病毒SARS-CoV-2传播时的错误。评《截至2020年4月SARS-CoV-2基因组可获得性的快照及其影响：数据分析》
JMIR Public Health Surveill. 2020 Nov 11;6(4):e23542. doi: 10.2196/23542.
10
[DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany - (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)].[德国关于结核病、卡介苗和新型冠状病毒肺炎（严重急性呼吸综合征冠状病毒2型引起的2019冠状病毒病的官方缩写）的建议]
Pneumologie. 2020 Jul;74(7):412-416. doi: 10.1055/a-1199-6721. Epub 2020 Jul 16.
引用本文的文献
1
Outcomes of the Unvaccinated Geriatric Population with Coronavirus Disease.未接种疫苗的老年新冠患者的结局
Sage Open Aging. 2025 Mar 29;11:30495334251330677. doi: 10.1177/30495334251330677. eCollection 2025 Jan-Dec.
2
Approach to COVID-19 in older adults and indications for improving the outcomes.老年人 COVID-19 的处理方法和改善预后的指征。
Ann Med. 2023;55(2):2265298. doi: 10.1080/07853890.2023.2265298. Epub 2023 Oct 15.
3
Sarcoidosis and COVID-19: At the Cross-Road between Immunopathology and Clinical Manifestation.结节病与新冠病毒病：处于免疫病理学与临床表现的十字路口
Biomedicines. 2022 Oct 9;10(10):2525. doi: 10.3390/biomedicines10102525.
4
Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses.自噬和线粒体自噬相关途径在家族性肉样瘤病相关遗传途径和冠状病毒引起的宿主-病原体相互作用的交汇点。
Cells. 2021 Aug 5;10(8):1995. doi: 10.3390/cells10081995.
5
The Chameleon Behavior of Sarcoidosis.结节病的变色龙行为
J Clin Med. 2021 Jun 24;10(13):2780. doi: 10.3390/jcm10132780.
6
Clinical Features and Diagnosis of Cardiac Sarcoidosis.心脏结节病的临床特征与诊断
J Clin Med. 2021 May 1;10(9):1941. doi: 10.3390/jcm10091941.
7
Sarcoidosis: An Old but Always Challenging Disease.结节病：一种古老但始终具有挑战性的疾病。
Diagnostics (Basel). 2021 Apr 14;11(4):696. doi: 10.3390/diagnostics11040696.
8
Chest Imaging of Patients with Sarcoidosis and SARS-CoV-2 Infection. Current Evidence and Clinical Perspectives.结节病与SARS-CoV-2感染患者的胸部影像学。当前证据与临床观点。
Diagnostics (Basel). 2021 Jan 27;11(2):183. doi: 10.3390/diagnostics11020183.
本文引用的文献
1
Efficacy of tocilizumab treatment in severely ill COVID-19 patients.托珠单抗治疗重症 COVID-19 患者的疗效。
Crit Care. 2020 Aug 27;24(1):524. doi: 10.1186/s13054-020-03224-7.
2
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
3
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study.接受生物改善病情抗风湿药（bDMARDs）和靶向合成改善病情抗风湿药（tsDMARDs）治疗的患者中COVID-19的易感性和严重程度：一项基于人群的研究。
Ann Rheum Dis. 2020 Jul;79(7):986-988. doi: 10.1136/annrheumdis-2020-217903. Epub 2020 May 28.
4
When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic.当游戏规则改变时：2019冠状病毒病大流行期间调整结节病管理的指南
Chest. 2020 Sep;158(3):892-895. doi: 10.1016/j.chest.2020.04.033. Epub 2020 Apr 29.
5
Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis.类风湿关节炎患者生物治疗中严重感染的风险：一项系统评价和荟萃分析。
Lancet. 2015 Jul 18;386(9990):258-65. doi: 10.1016/S0140-6736(14)61704-9. Epub 2015 May 11.
Zotero 插件